Karen B Whittington Selected Research

Immunosorbents

10/2016	Bone loss and aggravated autoimmune arthritis in HLA-DRβ1-bearing humanized mice following oral challenge with Porphyromonas gingivalis.
1/2016	The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen B Whittington Research Topics

Disease

8	Arthritis (Polyarthritis) 01/2022 - 01/2002
6	Rheumatoid Arthritis 01/2021 - 01/2002
3	Experimental Arthritis 04/2005 - 01/2002
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2002
1	Periodontal Diseases (Periodontal Disease) 10/2016
1	Inflammation (Inflammations) 07/2010

Drug/Important Bio-Agent (IBA)

6	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 01/2022 - 04/2004
6	Collagen Type II (Type II Collagen)IBA 01/2021 - 01/2002
5	HLA-DR Antigens (HLA-DR)IBA 01/2022 - 01/2002
2	AntigensIBA 01/2022 - 04/2004
2	EpitopesIBA 01/2021 - 10/2016
2	AutoantigensIBA 01/2021 - 07/2010
2	EnzymesIBA 10/2016 - 01/2016
2	ImmunosorbentsIBA 10/2016 - 01/2016
2	CytokinesIBA 10/2016 - 01/2002
2	Peptides (Polypeptides)IBA 06/2013 - 04/2004
1	AutoantibodiesIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	AntibodiesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Anti-Citrullinated Protein AntibodiesIBA 10/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Immunodominant EpitopesIBA 09/2006
1	CollagenIBA 04/2005
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 04/2004
1	TolerogenIBA 01/2002

Therapy/Procedure

1	Immunotherapy 01/2022